Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. - Uyttenhove,C.; Pilotte,L.; Theate,I.; Stroobant,V.; Colau,D.; Parmentier,N.; Boon,T.; Eynde,BJ Van den. (Nat Med, 2003)